KyungdongPharm Logo

KyungdongPharm

Develops and manufactures Rx/OTC drugs & APIs for cardiology and other chronic conditions.

011040 | KO

Overview

Corporate Details

ISIN(s):
KR7011040003
LEI:
Country:
South Korea
Address:
경기도 화성시 양감면 제약단지로 224-3, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1975, Kyung Dong Pharm is a pharmaceutical company specializing in the development, manufacturing, and sale of medical treatments. The company produces a diverse portfolio of prescription medicines, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs). Its core therapeutic areas include cardiology, endocrinology, gastroenterology, and urology, with a focus on treatments for conditions such as diabetes, hypertension, and hyperlipidemia. A key consumer product is the well-known OTC painkiller, 'Geunal-en'. Utilizing advanced manufacturing facilities and proprietary technology, Kyung Dong Pharm is committed to expanding its R&D pipeline and growing its global presence through exports.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 16.9 KB
2025-09-01 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 29.7 KB
2025-08-27 00:00
Major Shareholding Notification
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Korean 30.0 KB
2025-08-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 250.7 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 265.3 KB
2025-07-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.8 KB
2025-04-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 261.5 KB
2025-04-15 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.6 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.4 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.7 KB
2025-03-20 00:00
Annual Report
[첨부추가]사업보고서 (2024.12)
Korean 2.1 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 383.7 KB

Automate Your Workflow. Get a real-time feed of all KyungdongPharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KyungdongPharm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KyungdongPharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.